PharmaShots | Incisive News in 3 Shots

Subscribe Now

T cells

John Orwin, President, and CEO at Atreca Shares his Views on Developing Novel Therapies for Cancer

John Orwin, President, and CEO at Atreca Shares his Views on Developing Novel Therapies for Cancer

June 21, 2023

$Daiichi Sankyo Initiates P-I Study of DS-1055 for Relapsed/Refractory Advanced or Metastatic Solid Tumors$

Daiichi Sankyo Initiates P-I Study of DS-1055 for Relapsed/Refractory Advanced or Metastatic Solid Tumors

October 23, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us